• Bidirectionality of antiseizure and antipsychotic treatment: A population-based study 

      Revdal, Eline; Morken, Gunnar; Bakken, Inger Johanne; Bråthen, Geir; Landmark, Cecilie Johannessen; Brodtkorb, Eylert (Epilepsy & Behavior;Volume 136, November 2022, 108911, Peer reviewed; Journal article, 2022-09-17)
      Purpose: To study the prevalence and directionality of comorbid epilepsy and psychosis in Norway. Methods: The Norwegian Prescription Database (NorPD) provided individual-based information on all antiseizure medications ...
    • Clinical experience combined with therapeutic drug monitoringof lacosamide 

      Svendsen, Torleiv; Brodtkorb, Eylert; Baftiu, Arton; Lossius, Morten; Nakken, Karl Otto; Johannessen, Svein Ivar; Landmark, Cecilie Johannessen (Acta Neurologica Scandinavica;Volume 141, Issue 4, Journal article; Peer reviewed, 2019-12-14)
      Objective: Lacosamide (LCM) is an antiepileptic drug (AED) with insufficient clinical experience in patients with intellectual disability (ID). They often have more severe epilepsy with comorbidities. The objective was to ...
    • Reference ranges for antiepileptic drugs revisited: a practical approach to establish national guidelines 

      Reimers, Arne; Berg, Jon Andsnes; Burns, Margrete Larsen; Brodtkorb, Eylert; Johannessen, Svein Ivar; Landmark, Cecilie Johannessen (Journal article; Peer reviewed, 2018)
      Background and objective: Laboratories sometimes use different reference ranges for the same antiepileptic drug (AED), particularly for new and poorly investigated drugs. This may contribute to misunderstandings, concerns ...